Tandem Autologous versus Single Autologous Transplantation Followed by Allogeneic Hematopoietic Cell Transplantation for Patients with Multiple Myeloma: Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

BACKGROUND: Autologous hematopoietic cell transplantation (HCT) improves survival in patients with multiple myeloma, but disease progression remains a challenge. Allogeneic HCT (alloHCT) has the potential to reduce disease progression through graft-versus-myeloma effects. The aim of the BMT CTN 0102...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Krishnan, Amrita, Pasquini, Marcelo C., Logan, Brent, Stadtmauer, Edward A., Vesole, David H., Alyea, Edwin, Antin, Joseph H., Comenzo, Raymond, Goodman, Stacey, Hari, Parameswaran, Laport, Ginna, Qazilbash, Muzaffar H., Rowley, Scott, Sahebi, Firoozeh, Somlo, George, Vogl, Dan T., Weisdorf, Daniel, Ewell, Marian, Wu, Juan, Geller, Nancy L., Horowitz, Mary M., Giralt, Sergio, Maloney, David G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3611089/
https://ncbi.nlm.nih.gov/pubmed/21962393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70243-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia